Ashton Thomas Private Wealth’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$773K Sell
11,891
-4,611
-28% -$209K 0.02% 651
2026
Q2
$470K Buy
16,502
+11
+0.1% +$239 0.01% 806
2026
Q1
$286K Buy
+16,491
New +$312K 0.01% 900

Other funds holding CDNA

Ashton Thomas Private Wealth's CDNA Position: Q3 2026 in Review

Ashton Thomas Private Wealth reduced its CareDx (CDNA) stake by 28% in Q3 2026, selling an estimated $209K and leaving 11,891 shares worth $773K. The position accounts for 0.02% of the portfolio, ranked #651.

Ashton Thomas Private Wealth first reported a position in CDNA in Q1 2026 and has held it in 3 quarters since. 110 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Ashton Thomas Private Wealth held 11,891 shares of CareDx worth $773K as of Q3 2026.
  • Ashton Thomas Private Wealth sold 4,611 CareDx shares in Q3 2026, an estimated $209K.
  • CareDx made up 0.02% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #651 holding.
  • Ashton Thomas Private Wealth first reported a position in CareDx in Q1 2026 and has held it in 3 quarters since.
  • 110 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.